Orteronel (Ort) maintenance therapy in patients (pts) with metastatic castration resistant prostate cancer (mCRPC) and non-progressive disease after...

Date 26 September 2015
Event European Cancer Congress 2015
Session Genitourinary Malignancies - Prostate Cancer
Topics Prostate Cancer
Presenter Gillessen, S.